Cyclooxygenase metabolism mediates vasorelaxation to 2-arachidonoylglycerol (2-AG) in human mesenteric arteries

Pharmacological Research

Volumn 81, Issue , 2014, Pages 74-82

  Stanley, Christopher P ^a   O'Sullivan, Saoirse E ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

2 Arachidonoylglycerol; Cyclooxygenase; Endocannabinoid; Human; Prostanoid; Vasorelaxation

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ACYLGLYCEROL LIPASE; CALCIUM; CANNABINOID RECEPTOR; FATTY ACID AMIDASE; NITRIC OXIDE; POTASSIUM; PROSTAGLANDIN E RECEPTOR 4; PROSTAGLANDIN SYNTHASE; VANILLOID RECEPTOR 1; 2-ARACHIDONYLGLYCEROL; ACYLGLYCEROL; ARACHIDONIC ACID DERIVATIVE; CYCLOOXYGENASE 1; ENDOCANNABINOID; FLURBIPROFEN; INDOMETACIN; PROSTAGLANDIN SYNTHASE INHIBITOR; PTGS1 PROTEIN, HUMAN;

ARTERY CONSTRICTION; ARTERY DILATATION; ARTICLE; CALCIUM TRANSPORT; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME METABOLISM; EXTRACELLULAR CALCIUM; HUMAN; HUMAN TISSUE; MESENTERIC ARTERY; POTASSIUM TRANSPORT; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; DRUG EFFECTS; IN VITRO STUDY; PHYSIOLOGY; VASODILATATION;

ARACHIDONIC ACIDS; CYCLOOXYGENASE 1; CYCLOOXYGENASE INHIBITORS; ENDOCANNABINOIDS; FLURBIPROFEN; GLYCERIDES; HUMANS; IN VITRO TECHNIQUES; INDOMETHACIN; MESENTERIC ARTERIES; VASODILATION;

EID: 84895747977     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2014.02.001     Document Type: Article

References (61)

1. A. Quercioli, Z. Pataky, G. Vincenti, V. Makoundou, V. Di Marzo, and F. Montecucco et al. Elevated endocannabinoid plasma levels are associated with coronary circulatory dysfunction in obesity Eur Heart J 32 11 2011 1369 1378
2. M. Maccarrone Good news for CB1 receptors: endogenous agonists are in the right place Br J Pharmacol 153 2 2008 179 181
3. G.G. Muccioli Endocannabinoid biosynthesis and inactivation, from simple to complex Drug Discovery Today 15 11/12 2010 474 483
4. R. Mechoulam, S. Ben-Shabat, L. Hanus, M. Ligumsky, N.E. Kaminski, and A.R. Schatz et al. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors Biochem Pharmacol 50 1 1995 83 90
5. P.M. Zygmunt, J. Petersson, D.A. Andersson, H.-h. Chuang, M. Sorgard, and V. Di Marzo et al. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide Nature 400 6743 1999 452 457
6. Z. Jarai, J.A. Wagner, S.K. Goparaju, L. Wang, R.K. Razdan, and T. Sugiura et al. Cardiovascular effects of 2-arachidonoyl glycerol in anesthetized mice Hypertension 35 2 2000 679 684
7. K. Varga, J.A. Wagner, D.T. Bridgen, and G. Kunos Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension FASEB J 12 11 1998 1035 1044
8. K.M. Gauthier, D.V. Baewer, S. Hittner, C.J. Hillard, K. Nithipatikom, and D.S. Reddy et al. Endothelium-derived 2-arachidonylglycerol: an intermediate in vasodilatory eicosanoid release in bovine coronary arteries Am J Physiol Heart Circ Physiol 288 3 2005 H1344 H1351
9. W.S. Ho, and M.D. Randall Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol Br J Pharmacol 150 5 2007 641 651
10. F. Stanke-Labesque, M. Mallaret, B. Lefebvre, G. Hardy, F. Caron, and G. Bessard 2-Arachidonoyl glycerol induces contraction of isolated rat aorta: role of cyclooxygenase-derived products Cardiovasc Res 63 1 2004 155 160
11. S. Kagota, Y. Yamaguchi, K. Nakamura, T. Sugiura, K. Waku, and M. Kunitomo 2-Arachidonoylglycerol, a candidate of endothelium-derived hyperpolarizing factor Eur J Pharmacol 415 2-3 2001 233 238
12. D.M. Randall, A.D. Kendall, and O.S. Saoirse The complexities of the cardiovascular actions of cannabinoids Br J Pharmacol 142 1 2004 20 26
13. F. Montecucco, I. Matias, S. Lenglet, S. Petrosino, F. Burger, and G. Pelli et al. Regulation and possible role of endocannabinoids and related mediators in hypercholesterolemic mice with atherosclerosis Atherosclerosis 205 2 2009 433 441
14. K. Sugamura, S. Sugiyama, T. Nozaki, Y. Matsuzawa, Y. Izumiya, and K. Miyata et al. Activated endocannabinoid system in coronary artery disease and antiinflammatory effects of cannabinoid 1 receptor blockade on macrophages Circulation 119 1 2009 28 36
15. F. Weis, A. Beiras-Fernandez, R. Sodian, I. Kaczmarek, B. Reichart, and A. Beiras et al. Substantially altered expression pattern of cannabinoid receptor 2 and activated endocannabinoid system in patients with severe heart failure J Mol Cell Cardiol 48 6 2010 1187 1193
16. P.F. Wang, L.S. Jiang, J. Bu, X.J. Huang, W. Song, and Y.P. Du et al. Cannabinoid-2 receptor activation protects against infarct and ischemia-reperfusion heart injury J Cardiovasc Pharmacol 59 2012 301 307
17. S. Batkai, P. Pacher, D. Osei-Hyiaman, S. Radaeva, J. Liu, and J. Harvey-White et al. Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension Circulation 110 14 2004 1996 2002
18. D.J. Rademacher, S. Patel, W.S. Ho, A.M. Savoie, N.J. Rusch, and K.M. Gauthier et al. U-46619 but not serotonin increases endocannabinoid content in middle cerebral artery: evidence for functional relevance Am J Physiol Heart Circ Physiol 288 6 2005 H2694 H2701
19. J.A. Wagner, M. Abesser, J. Harvey-White, and G. Ertl 2-Arachidonylglycerol acting on CB1 cannabinoid receptors mediates delayed cardioprotection induced by nitric oxide in rat isolated hearts J Cardiovasc Pharmacol 47 5 2006 650 655
20. Q. Li, M. Shi, and B. Li Anandamide enhances expression of heat shock protein 72 to protect against ischemia-reperfusion injury in rat heart J Physiol Sci 63 2013 47 53
21. S. Steffens, N.R. Veillard, C. Arnaud, G. Pelli, F. Burger, and C. Staub et al. Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice Nature 434 7034 2005 782 786
22. P. Lepicier, J.F. Bouchard, C. Lagneux, and D. Lamontagne Endocannabinoids protect the rat isolated heart against ischaemia Br J Pharmacol 139 4 2003 805 815
23. T. Sugiura, T. Kodaka, S. Nakane, S. Kishimoto, S. Kondo, and K. Waku Detection of an endogenous cannabimimetic molecule, 2-arachidonoylglycerol, and cannabinoid CB1 receptor mRNA in human vascular cells: is 2-arachidonoylglycerol a possible vasomodulator? Biochem Biophys Res Commun 243 1998 838 843
24. M. Rajesh, P. Mukhopadhyay, S. Batkai, G. Hasko, L. Liaudet, and J.W. Huffman et al. CB2-receptor stimulation attenuates TNF-alpha-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion Am J Physiol Heart Circ Physiol 293 4 2007 H2210 H2218
25. M. Rajesh, P. Mukhopadhyay, G. Hasko, J.W. Huffman, K. Mackie, and P. Pacher CB2 cannabinoid receptor agonists attenuate TNF-alpha-induced human vascular smooth muscle cell proliferation and migration Br J Pharmacol 153 2008 347 357
26. G.B. Stefano, T.V. Bilfinger, C.M. Rialas, and D.G. Deutsch 2-arachidonyl-glycerol stimulates nitric oxide release from human immune and vascular tissues and invertebrate immunocytes by cannabinoid receptor 1 Pharmacol Res 42 4 2000 317 322
27. M.J. Mulvany, and W. Halpern Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats Circ Res 41 1 1977 19 26
28. E. Muller-Schweinitzer, M.J. Mihatsch, M. Schilling, and W.E. Haefeli Functional recovery of human mesenteric and coronary arteries after cryopreservation at -196 degrees C in a serum-free medium J Vasc Surg 25 4 1997 743 750
29. D. Harris, D.A. Kendall, and M.D. Randall Characterization of cannabinoid receptors coupled to vasorelaxation by endothelium-derived hyperpolarizing factor Naunyn-Schmiedeberg's Arch Pharmacol 359 1 1999 48 52
30. S. O'Sullivan, A.K. David, and D.R. Michael Heterogeneity in the mechanisms of vasorelaxation to anandamide in resistance and conduit rat mesenteric arteries Br J Pharmacol 142 3 2004 435 442
31. S.E. O'Sullivan, D.A. Kendall, and M.D. Randall Characterisation of the vasorelaxant properties of the novel endocannabinoid N-arachidonoyl-dopamine (NADA) Br J Pharmacol 141 5 2004 803 812
32. C. Yang, Y.W. Kwan, A.L. Au, C.C. Poon, Q. Zhang, and S.W. Chan et al. 14,15-Epoxyeicosatrienoic acid induces vasorelaxation through the prostaglandin EP(2) receptors in rat mesenteric artery Prostaglandins Other Lipid Mediat 93 2010 44 51
33. R.W. Balzary, and T.M. Cocks Lipopolysaccharide induces epithelium- and prostaglandin E(2)-dependent relaxation of mouse isolated trachea through activation of cyclooxygenase (COX)-1 and COX-2 J Pharmacol Exp Ther 317 2 2006 806 812
34. Y. Yamada, M. Iwasaki, H. Usui, K. Ohinata, E.D. Marczak, and A.W. Lipkowski et al. Rapakinin, an anti-hypertensive peptide derived from rapeseed protein, dilates mesenteric artery of spontaneously hypertensive rats via the prostaglandin IP receptor followed by CCK(1) receptor Peptides 31 5 2010 909 914
35. S.E. O'Sullivan, Y. Sun, A.J. Bennett, M.D. Randall, and D.A. Kendall Time-dependent vascular actions of cannabidiol in the rat aorta Eur J Pharmacol 612 1-3 2009 61 68
36. C.A. Rouzer, K. Ghebreselasie, and L.J. Marnett Chemical stability of 2-arachidonylglycerol under biological conditions Chem Phys Lipids 119 1/2 2002 69 82
37. S.E. O'Sullivan, D.A. Kendall, and M.D. Randall Vascular effects of [Delta]9-tetrahydrocannabinol (THC), anandamide and N-arachidonoyldopamine (NADA) in the rat isolated aorta Eur J Pharmacol 507 1-3 2005 211 221
38. C.J. Hillard, W.S. Ho, J. Thompson, K.M. Gauthier, C.E. Wheelock, and H. Huang et al. Inhibition of 2-arachidonoylglycerol catabolism modulates vasoconstriction of rat middle cerebral artery by the thromboxane mimetic, U-46619 Br J Pharmacol 152 5 2007 691 698
39. Y. Wang, J. Wang, C. Wang, J. Liu, L. Shi, and M. Xu et al. Functional expression of transient receptor potential vanilloid-related channels in chronically hypoxic human pulmonary arterial smooth muscle cells J Membr Biol 223 3 2008 151 159
40. I. Fantozzi, S. Zhang, O. Platoshyn, C.V. Remillard, R.T. Cowling, and X-J. Yuan Hypoxia increases AP-1 binding activity by enhancing capacitative Ca2+ entry in human pulmonary artery endothelial cells Am J Physiol Lung Cell Mol Physiol 285 6 2003 L1233 L1245
41. M. Desch, T. Schubert, A. Schreiber, S. Mayer, B. Friedrich, and F. Artunc et al. PPARgamma-dependent regulation of adenylate cyclase 6 amplifies the stimulatory effect of cAMP on renin gene expression Mol Endocrinol 24 11 2010 2139 2151
42. W.T. Wong, X.Y. Tian, A. Xu, J. Yu, C.W. Lau, and R.L. Hoo et al. Adiponectin is required for PPARgamma-mediated improvement of endothelial function in diabetic mice Cell Metab 14 1 2011 104 115
43. 3 independently of cannabinoid receptors 1 and 2 Mol Pharmacol 70 1 2006 101 111
44. S.E. O'Sullivan, D.A. Kendall, and M.D. Randall Time-dependent vascular effects of endocannabinoids mediated by peroxisome proliferator-activated receptor gamma (PPARgamma) PPAR Res 2009 2009 425289
45. 9- tetrahydrocannabinol J Pharmacol Exp Ther 317 1 2006 428 438
46. N. Zidar, K. Odar, D. Glavac, M. Jerse, T. Zupanc, and D. Stajer Cyclooxygenase in normal human tissues - is COX-1 really a constitutive isoform, and COX-2 an inducible isoform? J Cell Mol Med 13 9B 2009 3753 3763
47. K.R. Kozak, S.W. Rowlinson, and L.J. Marnett Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2 J Biol Chem 275 43 2000 33744 33749
48. C.A. Rouzer, and L.J. Marnett Glycerylprostaglandin synthesis by resident peritoneal macrophages in response to a zymosan stimulus J Biol Chem 280 29 2005 26690 26700
49. Q. Guo, L.H. Wang, and R.J. Kulmacz Role of Val509 in time-dependent inhibition of human prostaglandin H synthase-2 cyclooxygenase activity by isoform-selective agents J Biol Chem 271 32 1996 19134 19139
50. G.F. Fabiola, V. Pattabhi, and K. Nagarajan Structural basis for selective inhibition of COX-2 by nimesulide Bioorg Med Chem 6 12 1998 2337 2344
51. S.W. Rowlinson, J.R. Kiefer, J.J. Prusakiewicz, J.L. Pawlitz, K.R. Kozak, and A.S. Kalgutkar et al. A novel mechanism of cyclooxygenase-2 inhibition involving interactions with Ser-530 and Tyr-385 J Biol Chem 278 46 2003 45763 45769
52. C.S. Nirodi, B.C. Crews, K.R. Kozak, J.D. Morrow, and L.J. Marnett The glyceryl ester of prostaglandin E2 mobilizes calcium and activates signal transduction in RAW264.7 cells Proc Natl Acad Sci U S A 101 7 2004 1840 1845
53. K.R. Kozak, B.C. Crews, J.L. Ray, H.H. Tai, J.D. Morrow, and L.J. Marnett Metabolism of prostaglandin glycerol esters and prostaglandin ethanolamides in vitro and in vivo J Biol Chem 276 40 2001 36993 36998
54. R.A. Coleman, W.L. Smith, and S. Narumiya International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes Pharmacol Rev 46 2 1994 205 229
55. X. Norel Prostanoid receptors in the human vascular wall ScientificWorldJournal 7 2007 1359 1374
56. E. Herradón, M.I. Martín, and V. López-Miranda Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta Br J Pharmacol 152 5 2007 699 708
57. M. Abramovitz, M. Adam, Y. Boie, M. Carriere, D. Denis, and C. Godbout et al. The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs Biochim Biophys Acta 1483 2 2000 285 293
58. M.D. Randall, A.I. McCulloch, and D.A. Kendall Comparative pharmacology of endothelium-derived hyperpolarizing factor and anandamide in rat isolated mesentery Eur J Pharmacol 333 2/3 1997 191 197
59. R. White, W.S. Ho, F.E. Bottrill, W.R. Ford, and C.R. Hiley Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries Br J Pharmacol 134 4 2001 921 929
60. H. Kozlowska, M. Baranowska, E. Schlicker, M. Kozlowski, J. Laudanski, and B. Malinowska Identification of the vasodilatory endothelial cannabinoid receptor in the human pulmonary artery J Hypertens 25 11 2007 2240 2248 2210.1097/HJH.2240b2013e3282ef2247a2240a
61. R. White, and C.R. Hiley The actions of some cannabinoid receptor ligands in the rat isolated mesenteric artery Br J Pharmacol 125 3 1998 533 541